Evidence for a prostate cancer-susceptibility locus on chromosome 20.
about
The DNA sequence and comparative analysis of human chromosome 20Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancerPolymorphisms in mitochondrial genes and prostate cancer riskThe genetics of cancer riskMutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancerComparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility LociA missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in FinlandClinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record-Linked Genome-Wide Association Study: A Case Series.Clinical Correlates of Autosomal Chromosomal Abnormalities in an Electronic Medical Record-Linked Genome-Wide Association Study: A Case SeriesProstate Cancer Genetics: Variation by Race, Ethnicity, and Geography.Molecular genetics of human prostate cancer.Genetics of prostate cancer.Exploring the within- and between-class correlation distributions for tumor classification.Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q.A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity.Regression models for linkage heterogeneity applied to familial prostate cancerModel-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4.Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancerHPC2 variants and screen-detected prostate cancerAnalysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.Cytogenetics and molecular genetics of cancer of the prostate.Identification of P-Rex1 as a novel Rac1-guanine nucleotide exchange factor (GEF) that promotes actin remodeling and GLUT4 protein trafficking in adipocytesPharmacogenetics of human androgens and prostate cancer--an update.The genetics of cancer susceptibility: from mouse to man.Screening for familial and hereditary prostate cancer.The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.Molecular pathology of prostate cancer.Identification of a novel NBN truncating mutation in a family with hereditary prostate cancerIdentification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population.Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysisHereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.Genomic biomarkers, androgen pathway and prostate cancer.Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications.A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.Mutations in CHEK2 associated with prostate cancer risk.Analysis of the RNASEL gene in familial and sporadic prostate cancer.Prostate-specific antigen-based screening for prostate cancer in the third millennium: useful or hype?The complexity of prostate cancer: genomic alterations and heterogeneity.
P2860
Q21735926-2D8E96EA-9C9E-4180-AAB4-BDFA8AD9C058Q24536433-F73BFBD0-F762-46CC-A724-7E3D5C804EC1Q24647983-E7461CAF-D622-409B-8C6D-9945E6CC6E68Q27013910-206BA2BA-8BC0-4704-8036-58725575E7E3Q28236153-9640A848-0B9F-44FC-A68F-BAD5E2F50F90Q28290530-309D3079-6C2D-4D6B-BC43-03CA932C5368Q28365264-3A620FBF-AC6B-42E2-9165-4183BAE8EA2FQ28385298-71DF14F7-27ED-4BEF-A356-508CD0B37105Q28392193-0FF1DD39-0A1C-4F4F-BADA-68EA47A244B7Q30240027-F4AF5B73-C0DD-46FC-804C-D0E468AF7B90Q31039228-9AE0C416-0818-409C-8D18-E9CEB7E3A02CQ33723275-CE9BA0C3-90B4-4139-B6CD-E8DC963E1AAAQ33859180-533BD03A-4B75-490A-BF40-114EA93FC268Q33904602-7D2C4CE1-CEA8-4B61-95C5-685480417A64Q34020369-F27401AE-0300-4D5A-9BC6-1E26F24AF2C5Q34020676-95F6055A-58CE-4D9D-A74B-7382673BFF59Q34020687-0B5443FD-518E-425A-AA1A-AB4F227E8BD4Q34113343-9DBA0072-2D81-4084-A791-F006D0906224Q34114671-EC5DEE3E-3B58-4FD9-831C-89897F82B079Q34308746-210D0304-6041-4B79-BE88-6212E2CAF978Q34984193-50425D35-2CFE-4E2A-B26A-4F2EADFE5C9FQ35604609-82B5B6E9-066D-4A17-8DFE-9D852D5781C3Q35753329-A6A72650-8224-4AF4-A3BC-E54D92C4214CQ35812486-CECF4744-1135-4A39-A482-8E2475A5610BQ35861576-B6408F1B-A6CC-41C6-BE5B-232CF3DAB9E6Q35978229-B43874FF-5BCB-463C-8F0C-D6EFEEA009E8Q36190531-0C9BFD67-C912-4BD5-8FE1-E1F62473214CQ36249264-9055D2AF-BE10-4485-B351-0403D6ABA055Q36360805-27A5FF1B-56D0-4AA5-9D1C-D8DD4776224BQ36604157-7849FBE1-5A9B-4591-BA6A-E62C7389C200Q36648285-B8705460-503F-47F5-871A-95CCFCF78A95Q36686743-4DA8AD03-E7C8-4188-BCAF-6E41C033460CQ36696583-F5AC94CF-36D6-44E7-BCDB-11951806609BQ36845131-A662EB4C-613E-438F-BF91-956311077050Q37016023-10C4E35A-8EAA-445D-B55E-48040BC290B5Q37203309-A084B3EF-E3F4-44CD-9A5A-709D2C77406EQ37219438-BFFB691E-E3D2-42B4-AAD7-26095348DCD6Q37361805-28B936C7-831A-46B3-81F8-3B83EBD8322EQ37573519-07A00892-38F6-48C4-8AB6-63007BFBF35AQ38058243-54378F91-B07A-49A9-B42B-781BC4FC274A
P2860
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
@ast
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
@en
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
@nl
type
label
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
@ast
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
@en
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
@nl
prefLabel
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
@ast
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
@en
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
@nl
P2093
P2860
P356
P1476
Evidence for a prostate cancer-susceptibility locus on chromosome 20.
@en
P2093
A J French
B J Peterson
D J Schaid
J J Schroeder
S K McDonnell
S N Thibodeau
P2860
P356
10.1086/302994
P407
P577
2000-05-16T00:00:00Z